nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acceptability of human papillomavirus vaccines among women older than 26 years
|
Dempsey, Amanda F. |
|
2015 |
33 |
13 |
p. 1556-1561 6 p. |
artikel |
2 |
Assessing the economic benefits of vaccines based on the health investment life course framework: A review of a broader approach to evaluate malaria vaccination
|
Constenla, Dagna |
|
2015 |
33 |
13 |
p. 1527-1540 14 p. |
artikel |
3 |
Clinical manifestations of leprosy after BCG vaccination: An observational study in Bangladesh
|
Richardus, Renate A. |
|
2015 |
33 |
13 |
p. 1562-1567 6 p. |
artikel |
4 |
Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine
|
Delrieu, Isabelle |
|
2015 |
33 |
13 |
p. 1518-1526 9 p. |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
13 |
p. IFC- 1 p. |
artikel |
6 |
Healthcare worker influenza immunization vaccinate or mask policy: Strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness
|
Van Buynder, P.G. |
|
2015 |
33 |
13 |
p. 1625-1628 4 p. |
artikel |
7 |
HPV vaccine acceptance among adolescent males and their parents in two suburban pediatric practices
|
Khurana, Shalinee |
|
2015 |
33 |
13 |
p. 1620-1624 5 p. |
artikel |
8 |
Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation
|
Lee, Sung-Jong |
|
2015 |
33 |
13 |
p. 1549-1555 7 p. |
artikel |
9 |
Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses
|
Thompson, Kimberly M. |
|
2015 |
33 |
13 |
p. 1568-1577 10 p. |
artikel |
10 |
No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus
|
Helfer-Hungerbuehler, A. Katrin |
|
2015 |
33 |
13 |
p. 1578-1585 8 p. |
artikel |
11 |
Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013
|
Cheng, Daryl R. |
|
2015 |
33 |
13 |
p. 1602-1607 6 p. |
artikel |
12 |
Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
|
An, So Jung |
|
2015 |
33 |
13 |
p. 1614-1619 6 p. |
artikel |
13 |
Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L
|
Sansri, Veerawat |
|
2015 |
33 |
13 |
p. 1596-1601 6 p. |
artikel |
14 |
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
|
Hariri, Susan |
|
2015 |
33 |
13 |
p. 1608-1613 6 p. |
artikel |
15 |
Safety of vaccine adjuvants: Focus on autoimmunity
|
van der Laan, Jan Willem |
|
2015 |
33 |
13 |
p. 1507-1514 8 p. |
artikel |
16 |
The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines
|
Lopalco, Pier Luigi |
|
2015 |
33 |
13 |
p. 1541-1548 8 p. |
artikel |
17 |
The immunogenicity and safety of zoster vaccine in Taiwanese adults
|
Yao, Chien-An |
|
2015 |
33 |
13 |
p. 1515-1517 3 p. |
artikel |
18 |
The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model
|
Guo, Shanguang |
|
2015 |
33 |
13 |
p. 1586-1595 10 p. |
artikel |